Forex Today: Dollar in trouble as pandemic-related concerns were set aside

FXStreet Team FXStreet

Here is what you need to know on Tuesday, July 14:

Risk appetite dominated the financial world for most of this Monday, weighing on the American currency. The EUR/USD pair reached 1.1375, retreating ahead of the US close as Wall Street turned lower and closed in the red. There was no particular catalyst for equities slump, but profit-taking as the earnings season quick-starts this Tuesday.

The Pound was among the weakest, losing the 1.2600 level against the dollar way ahead of the U-turn in the market’s mood. No progress in Brexit talks and chatter about negative rates weighed on the Sterling.

The main theme is the ongoing pandemic. The number of global new coronavirus cases remains on the rise. Nevertheless, governments are trying to avoid new lockdowns, which somehow fueled the market’s positive sentiment throughout the day.

Also, the US FDA approved the Fast Track designation to the joint coronavirus vaccine efforts made by German BioNTech and US pharmaceutical Pfizer. Several vaccines seem to be making progress, another risk-on factor that got erased by equities slump at the end of the day.

China’s premier Li said that the economy is showing a steady recovery. The market took the headline with a pinch of salt. Additionally, China issued a travel advisory for Australia, with the ministry of foreign affairs citing racism, violence, and anti-Chinese sentiment.

The earnings season is starting this Tuesday with major banks Citigroup, JP Morgan, and Wells Fargo reports.

Commodities feel the heat at the end of the day but held within familiar levels. Gold settled at $1,804 a troy ounce, while WTI finished the day around $39.60 a barrel.

Cryptocurrency Market News: Vodafone and others are using Blockchain, Bitcoin is trying to hold $9,200

Author

FXStreet Team

FXStreet

EUR/USD remains offered below 1.1800, looks at US data

EUR/USD is still trading on the defensive in the latter part of Thursday’s session, while the US Dollar maintains its bid bias as investors now gear up for Friday’s key release of the PCE data, advanced Q4 GDP prints and flash PMIs.

GBP/USD bounces off monthly lows near 1.3430

GBP/USD is sliding in tandem with its risk-sensitive peers, drifting back towards the 1.3430 area, its lowest levels in the month. The move reflects a firmer Greenback, supported by another round of solid US data and a somewhat divided FOMC Minutes.

Gold surrenders some gains, back below $5,000

Gold is giving away part of its earlier gains on Thursday, receding to the sub-$5,000 region per troy ounce. The precious metal is finding support from renewed geopolitical tensions in the Middle East and declining US Treasury yields across the curve in a context of further advance in the Greenback.

XRP edges lower as SG-FORGE integrates EUR stablecoin on XRP Ledger

Ripple’s (XRP) outlook remains weak, as headwinds spark declines toward the $1.40 psychological support at the time of writing on Thursday.

Hawkish Fed minutes and a market finding its footing

It was green across the board for US Stock market indexes at the close on Wednesday, with most S&P 500 names ending higher, adding 38 points (0.6%) to 6,881 overall. At the GICS sector level, energy led gains, followed by technology and consumer discretionary, while utilities and real estate posted the largest losses.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments.